Sara Coca Membribes· @scocmem · X·· 14 hours agoScore70
Body
#ESMO26
Starting the Presidential Session with INTerpath-001
Intismeran + pembro shows ⬇️risk of recurrence and of distant mets including high-risk stages. A major step forward for personalised cancer vaccines, looking forward to see the data in other tumour types
@OncoAlert
32 views · 2 likes · 0 reposts · 0 replies
Conference abstracts
LBA1matched by Presidential Symposium I
INTerpath-001: Phase 3 study of the mRNA-based individualized neoantigen therapy (INT) intismeran autogene (intismeran) plus pembrolizumab (pembro) vs pembro alone for adjuvant treatment of resected stage IIB-IV melanoma (MEL)
https://esmocongress.esmo.orgINTerpath-001
https://esmocongress.esmo.orgSource: Sara Coca Membribes · x.com